Table 2 Summary of the association of CDH1 promoter methylation and ovarian cancer

NMT group

8

8.71(4.87 - 15.58)

16.6 %; 0.299

<0.001

435

255

0.335

Race

Asians

5

13.20 (6.12 - 28.45)

0.0 %; 0.545

<0.001

285

172

Caucasians

3

3.84 (1.52 - 9.74)

0.0 %; 0.380

0.005

150

83

LMT group

2

2.40 (0.86 - 6.76)

0.0 %; 0.512

0.096

109

37

Histology

Stage 1-2

Stage 3-4

4

1.41 (0.76 - 2.60)

0.0 %; 0.483

0.273

122

82

0.935

Stage

Serous

Non-serous

3

0.55 (0.28 - 1.08)

45.3 %; 0.161

0.082

57

142

0.316